🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
DRAGON III research, Neoadjuvant Chemotherapy (FLOT versus SOX) for Gastric...
Status
Not Yet Recruiting
Location
Ruijin Hospital Shanghai Jiaotong University School of Medicine
Start Date
2021-09
Trial ID
NCT04384601
Treatments Being Tested
To evaluate the clinical efficacy of perioperative treatment with S-1 + oxa...
Status
Recruiting
Location
Chiba Cancer Center
Start Date
2026-07-15
Trial ID
NCT07699939
Treatments Being Tested
This is a phase II open-label study to evaluate the efficacy and safety of ...
Status
Not Yet Recruiting
Location
Xijing Hospital, Air Force Medical University
Start Date
2026-07
Trial ID
NCT07685704
Treatments Being Tested
Chemotherapy, immune checkpoint inhibitors, and anti-angiogenic targeted th...
Status
Not Yet Recruiting
Location
Zhongnan Hospital of Wuhan University
Start Date
2025-04-01
Trial ID
NCT06464601
This is a single-arm, open, exploratory clinical study to evaluate the effi...
Status
Unknown
Location
The Third Affiliated Hospital of Sun Yat-sen University
Start Date
2022-09-20
Trial ID
NCT05545436
Treatments Being Tested
This study is a multicenter, randomized, uncontrolled clinical trial to eva...
Status
Active Not Recruiting
Location
Sichuan Cancer Hospital & Institute
Start Date
2024-11-21
Trial ID
NCT06693128
Treatments Being Tested
This is a randomized, multicenter, controlled, adaptive phase II/III clinic...
Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Start Date
2018-06-28
Trial ID
NCT03691454
Treatments Being Tested
The goal of this clinical trial is to learn if treatment modality including...
Status
Recruiting
Location
Peking University Cancer Hospital & Institute
Start Date
2025-05-20
Trial ID
NCT06992362
Treatments Being Tested
This study is to evaluate the efficacy and safety of different postoperativ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-30
Trial ID
NCT07161453
Abstract Objective: Adebrelimab is a PD-L1 inhibitor. The aim of this trial...
Status
Unknown
Location
The First Affiliated Hospital of the Air Force Medical University
Start Date
2023-12-30
Trial ID
NCT06192186
Treatments Being Tested